|
2012 Journal Article Advanced glycation end products as environmental risk factors for the development of type 1 diabetesYap, Felicia Y. T., Kantharidis, Phillip, Coughlan, Melinda T., Slattery, Robyn and Forbes, Josephine M. (2012). Advanced glycation end products as environmental risk factors for the development of type 1 diabetes. Current Drug Targets, 13 (4), 526-540. doi: 10.2174/138945012799499758 |
|
2012 Journal Article Glycation in diabetic nephropathyForbes, Josephine M. and Cooper, Mark E. (2012). Glycation in diabetic nephropathy. Amino Acids, 42 (4), 1185-1192. doi: 10.1007/s00726-010-0771-4 |
|
2012 Journal Article Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetesSourris, Karly C., Harcourt, Brooke E., Tang, Peter H., Morley, Amy L., Karina Huynh, Penfold, Sally A., Coughlan, Melinda T., Cooper, Mark E., Tuong-Vi Nguyen, Ritchie, Rebecca H. and Forbes, Josephine M. (2012). Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radical Biology and Medicine, 52 (3), 716-723. doi: 10.1016/j.freeradbiomed.2011.11.017 |
|
2012 Journal Article Obesity-induced renal impairment is exacerbated in interleukin-6-knockout miceHarcourt, Brooke E., Forbes, Josephine M. and Matthews, Vance B. (2012). Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice. Nephrology, 17 (3), 257-262. doi: 10.1111/j.1440-1797.2011.01547.x |
|
2011 Book Chapter Role of oxidative stress in diabetic nephropathyForbes, Josephine M., Coughlan, Melinda T. and Cooper, Mark E. (2011). Role of oxidative stress in diabetic nephropathy. Advances in Pathogenesis of Diabetic Nephropathy. (pp. 199-218) Nova Science Publishers, Inc.. |
|
2011 Journal Article Advanced glycation end products are direct modulators of β-cell functionCoughlan, Melinda T., Yap, Felicia Y. T., Tong, David C. K., Andrikopoulos, Sofianos, Gasser, Anna, Thallas-Bonke, Vicki, Webster, Diane E., Miyazaki, Jun-ichi, Kay, Thomas W., Slattery, Robyn M., Kaye, David M., Drew, Brian G., Kingwell, Bronwyn A., Fourlanos, Spiros, Groop, Per-Henrik, Harrison, Leonard C., Knip, Mikael and Forbes, Josephine M. (2011). Advanced glycation end products are direct modulators of β-cell function. Diabetes, 60 (10), 2523-2532. doi: 10.2337/db10-1033 |
|
2011 Journal Article Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in manCoughlan, Melinda T., Patel, Sheila K., Jerums, George, Penfold, Sally A., Nguyen, Tuong-Vi, Sourris, Karly C., Panagiotopoulos, Sianna, Srivastava, Piyush M., Cooper, Mark E., Burrell, Louise M., MacIsaac, Richard J. and Forbes, Josephine M. (2011). Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man. American Journal of Nephrology, 34 (4), 347-355. doi: 10.1159/000331064 |
|
2011 Conference Publication Ubiquinone Is Renoprotective in An Experimental Model of Type 2 DiabetesSourris, K. C., Morley, A. L., Harcourt, B. E., Penfold, S. A., Coughlan, M. T., Nugyen, T-V, Cooper, M. E., Ritchie, R. H. and Forbes, J. M. (2011). Ubiquinone Is Renoprotective in An Experimental Model of Type 2 Diabetes. WILEY-BLACKWELL. |
|
2011 Conference Publication Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine EstrogensHarcourt, B. E., Coughlan, M. T., Andrikopoulos, S., Thomas, M. C., Bruce, C., Febbraio, M. A., Nawroth, P., Bierhaus, A., Kantharidis, P., Cooper, M. E. and Forbes, J. M. (2011). Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine Estrogens. WILEY-BLACKWELL. |
|
2011 Journal Article The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinaseKrautwald, Martina, Leech, Dale, Horne, Stacey, Steele, Megan L., Forbes, Josephine, Rahmadi, Anton, Griffith, Renate and Muench, Gerald (2011). The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase. Rejuvenation Research, 14 (4), 383-391. doi: 10.1089/rej.2010.1143 |
|
2011 Journal Article Targeted reduction of advanced glycation improves renal function in obesityHarcourt, Brooke E., Sourris, Karly C., Coughlan, Melinda T., Walker, Karen Z., Dougherty, Sonia L., Andrikopoulos, Sofianos, Morley, Amy L., Thallas-Bonke, Vicki, Chand, Vibhasha, Penfold, Sally A., de Courten, Maximilian P. J., Thomas, Merlin C., Kingwell, Bronwyn A., Bierhaus, Angelika, Cooper, Mark E., de Courten, Barbora and Forbes, Josephine M. (2011). Targeted reduction of advanced glycation improves renal function in obesity. Kidney International, 80 (2), 190-198. doi: 10.1038/ki.2011.57 |
|
2011 Journal Article Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetesCoughlan, Melinda T. and Forbes, Josephine M. (2011). Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes. American Journal of Nephrology, 34 (1), 9-17. doi: 10.1159/000328581 |
|
2011 Conference Publication Detrimental Effects of Dietary Advanced Glycation End Products on Insulin Sensitivity in Healthy Overweight IndividualsDe Courten, Barbora, De Courten, Maximilian, Walker, Karen, Staznicky, Nora, Sourris, Karly, Dougherty, Sonia, Schlaich, Markus, Soldatos, Georgia and Forbes, Josephine (2011). Detrimental Effects of Dietary Advanced Glycation End Products on Insulin Sensitivity in Healthy Overweight Individuals. ALEXANDRIA: AMER DIABETES ASSOC. |
|
2011 Journal Article Erratum to: Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesForbes, J. M., Söderlund, J., Yap, F. Y. T., Knip, M., Andrikopoulos, S., Ilonen, J., Simell, O., Veijola, R., Sourris, K. C., Coughlan, M. T., Forsblom, C., Slattery, R., Bierhaus, A., Grey, S. T., Wessman, M., Yamamoto, H., Cooper, M. E. and Groop, P.-H. (2011). Erratum to: Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia, 54 (6), 1586-1587. doi: 10.1007/s00125-011-2145-1 |
|
2011 Journal Article Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetesForbes, J. M., Soderlund, J., Yap, F. Y. T., Knip, M., Andrikopoulos, S., Ilonen, J., Simell, O., Veijola, R., Sourris, K. C., Coughlan, M. T., Forsblom, C., Slattery, R., Grey, S. T., Wessman, M., Yamamoto, H., Bierhaus, A., Cooper, M. E. and Groop, P.-H. (2011). Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia, 54 (5), 1032-1042. doi: 10.1007/s00125-011-2058-z |
|
2011 Journal Article Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycansMangat, R., Su, J. W., Lambert, J. E., Clandinin, M. T., Wang, Y., Uwiera, R. R., Forbes, J. M., Vine, D. F., Cooper, M. E., Mamo, J. C. and Proctor, S. D. (2011). Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans. Diabetic Medicine, 28 (1), 61-72. doi: 10.1111/j.1464-5491.2010.03138.x |
|
2010 Journal Article The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposityHenstridge, Darren C., Forbes, Josephine M., Penfold, Sally A., Formosa, Melissa F., Dougherty, Sonia, Gasser, Anna, de Courten, Maximilian P., Cooper, Mark E., Kingwell, Bronwyn A. and de Courten, Barbora (2010). The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposity. Metabolism: Clinical and Experimental, 59 (11), 1556-1561. doi: 10.1016/j.metabol.2010.01.027 |
|
2010 Journal Article Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptorSourris, K. C., Morley, A. L., Koitka, A., Samuel, P., Coughlan, M. T., Penfold, S. A., Thomas, M. C., Bierhaus, A., Nawroth, P. P., Yamamoto, H., Allen, T. J., Walther, T., Hussain, T., Cooper, M. E. and Forbes, J. M. (2010). Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. Diabetologia, 53 (11), 2442-2451. doi: 10.1007/s00125-010-1837-2 |
|
2010 Journal Article The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the keyForbes, Josephine M. (2010). The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the key. American Journal of Pathology, 177 (4), 1600-1602. doi: 10.2353/ajpath.2010.100679 |
|
2010 Journal Article The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouseGiunti, Sara, Calkin, Anna C., Forbes, Josephine M., Allen, Terri J., Thomas, Merlin C., Cooper, Mark E. and Jandeleit-Dahm, Karin A. (2010). The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. American Journal of Physiology - Renal Physiology, 299 (3), F528-F535. doi: 10.1152/ajprenal.00127.2010 |
